April 16, 2021

View Xcenda award-winning research from AMCP 2021

Earlier in April, Xcenda was proud to support the AMCP 2021 virtual conference. View our award-winning research below. 

Current and anticipated digital therapeutics payer perspectives in the COVID-19 era

By: Annie Chang, PharmD; Alex Kilgore, PharmD; Song Lee, PharmD, MBA; Barbara Carpenter, BS; Tim Frank, CPC, LPTA; Benjamin Parcher, PharmD, MS

Gold medal

Evaluation of payer-initiated oncology clinical pathways: utilization trends, development, and barriers to implementation

By: Annie Yan, PharmD; Seth Cook, PharmD

Bronze medal

Are US payers getting to grips with cost-effectiveness analysis?

By: Michael Drummond, PhD; Jackie Gladman, BPE; Janet Hughes, MSE; Kai Yeung, PhD; Jon Campbell, PhD; Dan Ollendorf, PhD; Emily Tsiao, PharmD; Mitchell Wendover, BA; Paula Hilton, MHA; Allen Lising

Bronze medal

Current and future payment of cell and gene therapies

By: Diane Smith, PhD; Ana Stojanovska, BS; Matthew Sarnes, PharmD; Amanda O'Hora, BA

Trends in the uptake and impact of the Institute for Clinical and Economic Review value assessment framework in payer coverage decisions from 2016 to 2020

By: Minha Choi, PharmD, MS; Tasmina Hydery, PharmD, MBA, BCGP; Robin Tan, PhD; Linnea Tennant, PharmD, MBA, MS

An update on the budget impact of appropriate low-dose aspirin utilization for primary and secondary cardiovascular event prevention in the managed care setting

By: Rashad Carlton, PharmD, MSPH; Rosa Coppolecchia, DO, MPH, FACP, FACPM; Barb Lennert, RN, BSN, MAOM; Annie Yan, PharmD

Impact of the COVID-19 pandemic on the uptake of telehealth services: a survey of U.S. payers

By: Christopher Yost, PharmD; Michael Sporck, PharmD, MBA; Melissa McCart, PharmD, MS; Derek Louie, PharmD, MS